Dr Cordiner is a Specialty Registrar in Diabetes and Endocrinology and General Internal Medicine. She graduated from The University of Glasgow in 2010. Following this she completed a research post with The Royal Marsden Hospital in 2011 undertaking academic projects in oncology including interest in renal, gynaecology and melanoma. She returned to Glasgow to complete her Foundation and Core Medical Training and began her Specialty Registrar Training in Diabetes and Endocrinology.
Ruth moved to Dundee in February 2018 in order to undertake a 3 year period of full time study to obtain a PhD. She is currently working as a Clinical Research Fellow in the Division of Molecular and Clinical Medicine with Professor Ewan Pearson. Her research is funded by the Wellcome Trust. Ruth will be undertaking human physiological studies on metformin and sulphonylureas, with an aim of modernising their use, and better understanding their mechanism of action in patients with type 2 diabetes.
Ruth's research focuses on modernising the use of current drugs in type 2 diabetes, metformin and sulphonylureas.
- The Study of Sulphonylurea Synergy with Incretins (LOGIC)
This proof-of-concept physiological study will explore the hypothesis that there is a synergistic effect between low-dose sulphonylurea and augmentation of the incretin effect on the beta cell. LOGIC will also evaluate for effect of KCNJ11 genotype on physiological response.